MARKET NEWS

Thermo Fisher Scientific Expands API Manufacturing Capabilities
Ocugen & CanSinoBIO Enter Strategic Co-Development & Manufacturing Partnership
Novel Silica Delivery System Enters Final Preclinical Development Stage
TrakCel Announces Strategic Partnership With WuXi AppTec Advanced Therapies
AGTC & Otonomy Announce Strategic Collaboration to Develop & Commercialize Gene Therapy 
North America Leads in Number of Strategic Pharma Partnerships

  FEATURED EDITORIAL

  COMPANY PROFILE

We are your trusted global partner for the development and supply of commercial quantities of functionalized PEGs (polyethylene glycols). Those in turn, are essential for your PEGylated therapeutic proteins for drug delivery. Our offerings include high-purity materials for use in investigational products in every phase of clinical development and in commercialized products. We understand that you care about rapid and cost-effective time to market. Therefore, setting the right quality attributes for the functionalized PEG is crucial for the manufacturing and stability of your PEGylated product — we can help you get it right. And during the marketing phase, expertise in life-cycle management and regulatory affairs can help you safeguard your compliance. Click here for more.

  EXCLUSIVE ONLINE CONTENT

FORMULATION FORUM - Rational Design & Development of Long-Acting Injectable Dosage Forms

Due to the advantages of parenteral sustained-release drug delivery (also known as long-acting injectables, LAIs) different types of sustained-release injectable delivery systems have been….

Cue Biopharma Doses First Patient in Clinical Trial

Cue Biopharma Doses First Patient in Clinical Trial

Cue Biopharma, Inc. recently announced it dosed the first patient in a Phase 1 clinical trial of CUE-101 at Washington University, Alvin J. Siteman Cancer Center, St. Louis, Missouri for the treatment of….

VivaLNK Delivers Continuomics Using Wearable Medical Sensors

VivaLNK Delivers Continuomics Using Wearable Medical Sensors

VivaLNK, a leading provider of connected healthcare solutions, is improving clinical trials with continuomics by using wearable medical sensors for….

Cabaletta Bio Receives IND Clearance From FDA to Initiate First Clinical Trial

Cabaletta Bio Receives IND Clearance From FDA to Initiate First Clinical Trial

Cabaletta Bio, Inc. recently announced it has received clearance of its IND application from the US FDA to initiate a first-in-human clinical trial of…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 16 – Bioavailability
October 23 – Capsules